Viola Mong Meehan - 30 May 2026 Form 4 Insider Report for Cue Biopharma, Inc. (CUE)

Reporting relationship: Director
Issuer ticker: CUE
Reported as of: 30 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jun 2026, 20:42:01 UTC
Next SEC filing: 10 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael Meluzio, Attorney-in-Fact

Key filing fact

Viola Mong Meehan filed Form 4 for Cue Biopharma, Inc. (CUE) on 02 Jun 2026.

Key facts

This page summarizes Viola Mong Meehan's Form 4 filing for Cue Biopharma, Inc. (CUE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Jun 2026, 20:42.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002137444 Primary reporting owner

Meehan Viola Mong

Relationship: Director
Address: C/O CUE BIOPHARMA, INC., 40 GUEST STREET, BOSTON
Signature: /s/ Michael Meluzio, Attorney-in-Fact
Signature date: 02 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CUE transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +1,626
Change %
Price: $0.000000^*
Shares after: 1,626
Date: 30 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,626
Exercise price: $21.90
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying the option are scheduled to vest over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments.